Literature DB >> 33811536

A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H.

Peng Li1, Feng Hou2, Sai Wang1, Ningning Luo3, Yingxue Qi3, Yongjie Wang4.   

Abstract

Entities:  

Year:  2021        PMID： 33811536     DOI： 10.1007/s00432-021-03622-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  10 in total

1.  Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.

Authors:  Kazuhito Sato; Masahito Kawazu; Yoko Yamamoto; Toshihide Ueno; Shinya Kojima; Genta Nagae; Hiroyuki Abe; Manabu Soda; Takafumi Oga; Shinji Kohsaka; Eirin Sai; Yoshihiro Yamashita; Hisae Iinuma; Masashi Fukayama; Hiroyuki Aburatani; Toshiaki Watanabe; Hiroyuki Mano
Journal:  Clin Cancer Res       Date:  2018-10-02       Impact factor: 12.531

2.  NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.

Authors:  James P Solomon; Irina Linkov; Andrea Rosado; Kerry Mullaney; Ezra Y Rosen; Denise Frosina; Achim A Jungbluth; Ahmet Zehir; Ryma Benayed; Alexander Drilon; David M Hyman; Marc Ladanyi; Anthony N Sireci; Jaclyn F Hechtman
Journal:  Mod Pathol       Date:  2019-08-02       Impact factor: 7.842

Review 3.  Identifying patients with NTRK fusion cancer.

Authors:  J P Solomon; R Benayed; J F Hechtman; M Ladanyi
Journal:  Ann Oncol       Date:  2019-12-24       Impact factor: 32.976

4.  Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing.

Authors:  Russell Bonneville; Melanie A Krook; Hui-Zi Chen; Amy Smith; Eric Samorodnitsky; Michele R Wing; Julie W Reeser; Sameek Roychowdhury
Journal:  Methods Mol Biol       Date:  2020

Review 5.  NTRK fusion-positive cancers and TRK inhibitor therapy.

Authors:  Emiliano Cocco; Maurizio Scaltriti; Alexander Drilon
Journal:  Nat Rev Clin Oncol       Date:  2018-12       Impact factor: 66.675

Review 6.  Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2019-12-17       Impact factor: 7.658

7.  Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients.

Authors:  Ari Vanderwalde; David Spetzler; Nianqing Xiao; Zoran Gatalica; John Marshall
Journal:  Cancer Med       Date:  2018-02-13       Impact factor: 4.452

8.  Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.

Authors:  Yuan-Sheng Zang; Chun Dai; Xiaoman Xu; Xin Cai; Guan Wang; Jinwang Wei; Angela Wu; Wending Sun; Shunchang Jiao; Qiang Xu
Journal:  Cancer Med       Date:  2019-07-04       Impact factor: 4.452

9.  Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity.

Authors:  Stipan Jonjic; Ofer Mandelboim; Adi Reches; Yael Ophir; Natan Stein; Inbal Kol; Batya Isaacson; Yoav Charpak Amikam; Afek Elnekave; Pinchas Tsukerman; Paola Kucan Brlic; Tihana Lenac; Barbara Seliger
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

Review 10.  Microsatellite instability: a review of what the oncologist should know.

Authors:  Kai Li; Haiqing Luo; Lianfang Huang; Hui Luo; Xiao Zhu
Journal:  Cancer Cell Int       Date:  2020-01-13       Impact factor: 5.722
  10 in total
  1 in total

Review 1.  Update in TIGIT Immune-Checkpoint Role in Cancer.

Authors:  Tiziana Annese; Roberto Tamma; Domenico Ribatti
Journal:  Front Oncol       Date:  2022-05-17       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.